IQVIA Holdings Inc. (IQV) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $175.28. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of IQV = $294.48 (+68% from the current price, the stock appears undervalued). Analyst consensus target is IQV = $234 (+33.4% upside).
Valuation: IQV trades at a trailing Price-to-Earnings (P/E) of 21.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.96.
Financials: revenue is $16.3B, +4.2%/yr average growth. Net income is $1.4B, growing at +8.2%/yr. Net profit margin is 8.3% (thin). Gross margin is 26.3% (-8.6 pp trend).
Balance sheet: total debt is $16.2B against $6.5B equity (Debt-to-Equity (D/E) ratio 2.49, leveraged). Current ratio is 0.75 (tight liquidity). Debt-to-assets is 54%. Total assets: $29.9B.
Analyst outlook: 37 / 44 analysts rate IQV as buy (84%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 63/100 (Pass), Growth 55/100 (Partial), Past 100/100 (Pass), Health 17/100 (Fail), Moat 48/100 (Partial), Future 94/100 (Pass), Income 45/100 (Partial).
